Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
US7550256B2 · kind B2 · utility
2Cited by
18References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 2003 |
| Grant date | Jun 23, 2009 |
| Priority date | — |
| Expiry date | Dec 15, 2023 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed are methods for detecting multidrug resistance in neoplastic or damaged cells or multidrug resistant (MDR) neoplastic or damaged cells by detecting an increase in the cell surface expression of vimentin protein in such cells as compared to the level of cell surface expression of vimentin protein in a normal cell or a non-MDR neoplastic cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.